Javascript must be enabled to continue!
Catecholamine use and post-interventional patient care after transcatheter tricuspid valve replacement
View through CrossRef
Abstract
Introduction
Severe tricuspid regurgitation (TR) is a prevalent condition in the general population and is associated with high morbidity and mortality. Interventional treatment of TR is increasingly performed. Transcatheter tricuspid valve replacement (TTVR) is a recently developed technique that can eliminate TR.
Purpose
Investigating the impact of eliminating high-grade TR on post-interventional patient care, acute heart failure, and catecholamine use in patients treated with TTVR.
Methods
The current study included all patients treated with TTVR at a single center. Post-interventional patient care was conducted according to established clinical routines. Blood lactate levels were measured using blood gas analyses. Patients were divided into two groups: the first group required catecholamines for more than one day after the procedure, while the second group did not. Clinical, laboratory, invasive hemodynamic, and echocardiographic parameters were compared between the two groups.
Results
A total of 29 patients were treated over approximately one year. The baseline TR was graded as severe to torrential in all patients. All patients showed a TR grade of less than 1 after TTVR. Nine patients needed catecholamines more than one day after the procedure, which could be tapered over the next 16 days. No patient died during the hospital stay. We did not observe a relevant increase in blood lactate levels after TTVR. Comparisons between the groups revealed a significantly lower left ventricular (LV) ejection fraction (EF) before TTVR in group 1. Left ventricular volume increased more in group 1 than in group 2 after TTVR.
Conclusion
TTVR may prolong catecholamine use but is not linked to fatal cardiogenic shock. Low LV EF best predicts post-TTVR catecholamine need. Patients who rely on catecholamines for an extended period after TTVR exhibit increased LV volume.Catecholamine use and ICU stay afterTTVR Central Illustration
Title: Catecholamine use and post-interventional patient care after transcatheter tricuspid valve replacement
Description:
Abstract
Introduction
Severe tricuspid regurgitation (TR) is a prevalent condition in the general population and is associated with high morbidity and mortality.
Interventional treatment of TR is increasingly performed.
Transcatheter tricuspid valve replacement (TTVR) is a recently developed technique that can eliminate TR.
Purpose
Investigating the impact of eliminating high-grade TR on post-interventional patient care, acute heart failure, and catecholamine use in patients treated with TTVR.
Methods
The current study included all patients treated with TTVR at a single center.
Post-interventional patient care was conducted according to established clinical routines.
Blood lactate levels were measured using blood gas analyses.
Patients were divided into two groups: the first group required catecholamines for more than one day after the procedure, while the second group did not.
Clinical, laboratory, invasive hemodynamic, and echocardiographic parameters were compared between the two groups.
Results
A total of 29 patients were treated over approximately one year.
The baseline TR was graded as severe to torrential in all patients.
All patients showed a TR grade of less than 1 after TTVR.
Nine patients needed catecholamines more than one day after the procedure, which could be tapered over the next 16 days.
No patient died during the hospital stay.
We did not observe a relevant increase in blood lactate levels after TTVR.
Comparisons between the groups revealed a significantly lower left ventricular (LV) ejection fraction (EF) before TTVR in group 1.
Left ventricular volume increased more in group 1 than in group 2 after TTVR.
Conclusion
TTVR may prolong catecholamine use but is not linked to fatal cardiogenic shock.
Low LV EF best predicts post-TTVR catecholamine need.
Patients who rely on catecholamines for an extended period after TTVR exhibit increased LV volume.
Catecholamine use and ICU stay afterTTVR Central Illustration.
Related Results
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
One-Year Outcomes of Screen Failures for Transcatheter Tricuspid Valve Repair: Insights From the TriSelect Study
One-Year Outcomes of Screen Failures for Transcatheter Tricuspid Valve Repair: Insights From the TriSelect Study
BACKGROUND:
Observational registries have shown improved survival among patients with severe or greater tricuspid regurgitation (TR) undergoing transcatheter tr...
Redo isolated tricuspid valve replacement in a patient with isolated persistent left superior vena cava: a case report
Redo isolated tricuspid valve replacement in a patient with isolated persistent left superior vena cava: a case report
Abstract
Background
Redo isolated tricuspid valve surgery has high in-hospital mortality and morbidity and is a challenging procedure. We report a s...
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED] Keanu Reeves CBD Gummies v1
[RETRACTED]Keanu Reeves CBD Gummies ==❱❱ Huge Discounts:[HURRY UP ] Absolute Keanu Reeves CBD Gummies (Available)Order Online Only!! ❰❰= https://www.facebook.com/Keanu-Reeves-CBD-G...
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Comparison of Valveplasty and Replacement for Surgical Treatment of Infective Tricuspid Valve Endocarditis
Abstract
Background
In recent years, due to the increase in intravenous drug injection and intracardiac and vascular interventional treatments among drug users, infective ...
Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
Assessment of STS-TR score for transcatheter tricuspid valve interventions: an international multicenter study
Abstract
Background
Transcatheter tricuspid valve intervention (TTVI) is increasingly utilized for symptomatic severe tri...
A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation
A Novel Transcatheter Edge-to-Edge Suturing Technique and Prototype for Repairing Tricuspid Valve Regurgitation
Abstract
Tricuspid valve regurgitation is a major clinical issue that continues to attract interest from interventional cardiologists and medical device designers du...
Concomitant tricuspid repair in mitral regurgitation surgery: a systematic review and meta-analysis
Concomitant tricuspid repair in mitral regurgitation surgery: a systematic review and meta-analysis
Abstract
Background
Tricuspid Regurgitation (TR) is common in patients with severe mitral disease. However, the evidence is insu...

